Compounds > azacitidine

azacitidine and Adrenal Cancer

azacitidine has been researched along with Adrenal Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fliedner, S; Giubellino, A; Korgaonkar, PG; Pacak, K; Powers, JF; Sahagian, GG; Tischler, AS1
Arvia, R; Deledda, C; Gelmini, S; Luciani, P; Malentacchi, F; Mannelli, M; Orlando, C; Peri, A; Simi, L1
Guijarro-Llorca, J; Toledo-Alberola, F1
Bernal, ML; Gomez, A; Ingelman-Sundberg, M; Johansson, I; Karlgren, M; Oliw, E; Ramón y Cajal, S; Rodriguez-Antona, C; Stark, K; Svärd, J1
Agathanggelou, A; Astuti, D; Cummins, C; Dahia, P; Dallol, A; Eng, C; Honorio, S; Kogner, P; Latif, F; Maher, ER; Martinsson, T; Neumann, HP; Voutilainen, R1

Other Studies

5 other study(ies) available for azacitidine and Adrenal Cancer

ArticleYear
Cytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell lines.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Azacitidine; Cell Death; Cell Line, Tumor; Humans; Mice; Paraganglioma; Pheochromocytoma; Topoisomerase I Inhibitors

2014
Seladin-1 expression is regulated by promoter methylation in adrenal cancer.
    BMC cancer, 2010, May-13, Volume: 10

    Topics: Adrenal Gland Neoplasms; Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Messenger; Time Factors

2010
Rapidly growing ulcer in a patient with neurofibromatosis type I.
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:1

    Topics: Adrenal Gland Neoplasms; Antimetabolites, Antineoplastic; Azacitidine; Fatal Outcome; Humans; Hypothyroidism; Immunocompromised Host; Leg Ulcer; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neoplasms, Second Primary; Neurofibromatosis 1; Pheochromocytoma; Pseudomonas Infections; Staphylococcal Infections

2012
Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.
    Biochemical and biophysical research communications, 2006, Mar-10, Volume: 341, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Arachidonic Acid; Azacitidine; Blotting, Western; Catalysis; Cell Line; Cell Line, Tumor; Cloning, Molecular; Colon; Colonic Neoplasms; CpG Islands; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Decitabine; DNA Methylation; Exons; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Introns; Mixed Function Oxygenases; Protein Folding; Protein Isoforms; Rats; RNA, Messenger; Transfection

2006
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Oncogene, 2001, Nov-08, Volume: 20, Issue:51

    Topics: Adrenal Gland Neoplasms; Alleles; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Caspase 8; Caspase 9; Caspases; Chromosomes, Human, Pair 3; CpG Islands; DNA Methylation; DNA Mutational Analysis; Gene Deletion; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Microsatellite Repeats; Molecular Sequence Data; Mutation; Neoplasm Proteins; Neuroblastoma; Phenotype; Pheochromocytoma; Prognosis; Promoter Regions, Genetic; Tumor Suppressor Proteins

2001